Tsubota Laboratory Incorporated
4890.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.49 | 0.05 | 0.10 | -0.78 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -62.68 | -45.36 | 51.12 | 287.41 |
| Quality | ||||
| ROIC | -9.72% | -14.74% | 6.60% | 0.95% |
| Gross Margin | 92.70% | 48.39% | 79.40% | 79.80% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 29.46% | 21.79% | 23.17% | 25.49% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 10.41 | 7.05 | -8.56 | -57.02 |
| Interest Coverage | -728.88 | -1,125.44 | 540.18 | 110.54 |
| Efficiency | ||||
| Inventory Turnover | 0.02 | 0.04 | 0.41 | 0.22 |
| Cash Conversion Cycle | 4,297.96 | 2,176.70 | 212.74 | 347.67 |